Greenwich LifeSciences, Inc.GLSINASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating

Buy

2 analysts·Low coverage

100%

Rating Distribution

Strong Buy

00%

Buy

2100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 98% higher.

Bear Case

$50.00

+98%

Consensus

$50.00

+98%

Bull Case

$50.00

+98%

Price Range2 analysts

Low

Consensus

High

$50.00

Current Target

Current Price

$25.19

Upside to Target

$24.81

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-1.36(2 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev—

EPS—

FY2028

Rev+1500.00%

EPS—

FY2029

Rev+121.88%

EPS+148.74%

Earnings Surprises

Beat rate:42%(5/12 quarters)

Avg surprise:-12.8%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Dec 30, 2025H.C. Wainwright

Greenwich LifeSciences price target raised to $50 from $39 at H.C. Wainwright

Target:$50.00

+101.8%from $24.78

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance